Jefferies Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-19,865	Closed	-$1.69M	–	1816
2021 Q4	$1.69M	Sell	19,865 -6,942	-26%	-$639K	0.01%	848
2021 Q3	$2.57M	Sell	26,807 -14,736	-35%	-$1.39M	0.02%	675
2021 Q2	$4.04M	Buy	41,543 +6,483	+18%	+$621K	0.03%	527
2021 Q1	$3.41M	Buy	35,060 +35,001	+59,324%	+$3.67M	0.03%	505
2020 Q4	$5.66K	Sell	59 -34,518	-100%	-$3.33M	﹤0.01%	1524
2020 Q3	$3.33M	Buy	34,577 +27,327	+377%	+$3.16M	0.04%	388
2020 Q2	$885	Sell	7,250 -27,796	-79%	-$3.07M	0.01%	792
2020 Q1	$3.03M	Sell	35,046 -16,233	-32%	-$1.59M	0.03%	501
2019 Q4	$5.51M	Sell	51,279 -93,066	-64%	-$9.74M	0.04%	474
2019 Q3	$13M	Buy	144,345 +74,173	+106%	+$6.93M	0.1%	149
2019 Q2	$5.92M	Buy	70,172 +67,615	+2,644%	+$5.55M	0.04%	393
2019 Q1	$225K	Sell	2,557 -53,689	-95%	-$4.49M	﹤0.01%	1908
2018 Q4	$4.02M	Buy	56,246 +3,123	+6%	+$299K	0.03%	506
2018 Q3	$6.53M	Sell	53,123 -17,755	-25%	-$2.01M	0.04%	426
2018 Q2	$6.96M	Buy	70,878 +65,878	+1,318%	+$5.9M	0.04%	387
2018 Q1	$415K	Sell	5,000 -1,868	-27%	-$158K	﹤0.01%	1603
2017 Q4	$533K	Buy	6,868 +3,519	+105%	+$240K	﹤0.01%	1697
2017 Q3	$205K	Buy	+3,349	New	+$177K	﹤0.01%	2066
2017 Q1	–	Sell	-9,216	Closed	-$357K	–	2544
2016 Q4	$357K	Sell	9,216 -4,494	-33%	-$203K	﹤0.01%	1705
2016 Q3	$694K	Buy	13,710 +6,707	+96%	+$334K	﹤0.01%	1466
2016 Q2	$318K	Buy	+7,003	New	+$322K	﹤0.01%	1641
2014 Q1	–	Sell	-12,396	Closed	-$116K	–	2271
2013 Q4	$116K	Buy	12,396 +12,200	+6,224%	+$119K	﹤0.01%	1684
2013 Q3	$2K	Sell	196 -312	-61%	-$4.29K	﹤0.01%	1871
2013 Q2	$7K	Buy	+508	New	+$6.24K	﹤0.01%	1767